Market closed

Revolution Medicines/$RVMD

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About Revolution Medicines

Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs.

Ticker

$RVMD
Trading on

Industry

Biotechnology

Employees

490

RVMD Metrics

BasicAdvanced
$10B
Market cap
-
P/E ratio
-$3.56
EPS
1.40
Beta
-
Dividend rate
$10B
1.4
$60.59
$19.05
1.4M
14.244
13.977
5
5.536
-2,071.61%
-28.56%
-47.18%
12,759.14
6.35
6.66
-17.177
-97.16%
7.43%
-70.42%
14.38%

What the Analysts think about RVMD

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Revolution Medicines stock.

RVMD Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

RVMD Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $RVMD

$

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Revolution Medicines stock?

Revolution Medicines (RVMD) has a market cap of $10B as of November 14, 2024.

What is the P/E ratio for Revolution Medicines stock?

The price to earnings (P/E) ratio for Revolution Medicines (RVMD) stock is 0 as of November 14, 2024.

Does Revolution Medicines stock pay dividends?

No, Revolution Medicines (RVMD) stock does not pay dividends to its shareholders as of November 14, 2024.

When is the next Revolution Medicines dividend payment date?

Revolution Medicines (RVMD) stock does not pay dividends to its shareholders.

What is the beta indicator for Revolution Medicines?

Revolution Medicines (RVMD) has a beta rating of 1.4. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.